Note 9 - Segment Information

3 Months Ended

Sep. 30, 2015

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note 9. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the three months ended September 30, 2015 and 2014 were $1,992 and $2,283, respectively.

Financial information relating to the three months ended September 30, 2015 and 2014 operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2015	$	6,930	$	1,815	$	8,745	$	1,041	$	59	$	54
	2014		5,743		2,065		7,808		1,151		60		351
Branded Proprietary Products	2015		147		172		319		128		-		-
	2014		129		210		339		6		-		1
Other Nutraceutical Businesses	2015		376		5		381		146		-		1
	2014		427		8		435		144		1		-
Total Company	2015		7,453		1,992		9,445		1,315		59		55
	2014		6,299		2,283		8,582		1,301		61		352

	Total Assets as of
	September 30,		June 30,
	2015		2015
Contract Manufacturing	$	9,113	$	8,482
Branded Proprietary Products		1,296		1,324
Other Nutraceutical Businesses		1,668		1,817
Total Company	$	12,077	$	11,623